OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	72
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	51
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	47
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	21
Deficits in our understanding of natural killer cell development in mouse and human	21
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	20
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	18
Disparities in acute myeloid leukemia treatments and outcomes	17
Mechanisms of immunothrombosis in COVID-19	17
Mesenchymal stromal cells: an update	17
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	16
Developmental regulation of primitive erythropoiesis	16
Platelet lifespan and mechanisms for clearance	15
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	15
The impact of obesity-induced inflammation on clonal hematopoiesis	14
Congenital neutropenia: disease models guiding new treatment strategies	14
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	13
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	12
High-throughput genotyping tools for red blood cell antigens	12
Humanized murine models of platelet function	11
Advances on the genetic basis of red cell membrane disorders	11
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia	10

Multifaceted roles of CRISPR technology in blood cancer research	10
Editorial introductions	10
Editorial introduction	9
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	9
Editorial introductions	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	8
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	8
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	8
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
Editorial introductions	7
Editorial introductions	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	7
Current Opinion in Hematology	7
Understanding and targeting erythroid progenitor cells for effective cancer therapy	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	6
Modelling arterial thrombus formation in vitro	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
The immunology of PF4 polyanion interactions	6
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	6
Translation defects in ribosomopathies	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	5
Chediak-Higashi syndrome	5
Platelets and platelet–leukocyte interactions in infectious diseases	5
Platelet transfusion	5
Editorial introduction	5
The state of prediction models in hematologic disease: a worrisome assessment	5
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	5
The fulfilled promise and unmet potential of umbilical cord blood	4
Novel approaches to measure transfusion effectiveness	4
Azacitidine maintenance in AML post induction and posttransplant	4
Editorial introduction	4
Platelet mitochondria: the mighty few	4
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	4
Editorial introductions	4
The congenital dyserythropoieitic anemias: genetics and pathophysiology	4
Recent advances in factor XII structure and function	4
Immunomodulatory roles of red blood cells	4
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	4
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	4
Editorial introduction	4
Editorial introduction	3
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	3
Red cell extracellular vesicles and coagulation activation pathways	3
Pediatric acute myeloid leukemia – novel approaches	3
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	3
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis	3

Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	3
Donor selection in allogeneic stem cell transplantation	3
Hematopoietic stem cell collection for sickle cell disease gene therapy	3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	3
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	3
Macrocytic anemias	3
Epigenetics of hematopoietic stem cell aging	3
Age-related micro-environmental changes as drivers of clonal hematopoiesis	3
Scoring systems to predict thrombotic complications in solid tumor patients	3
N6-methyladenosine in hematological malignancies: a concise review	3
The impact of prenatal inflammation on hematopoietic development	3
Editorial introduction	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	2
Immunologic effects of red blood cell and platelet transfusions in neonates	2
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance	2
PIEZO1, sensing the touch during erythropoiesis	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
Histological differences among thrombi in thrombotic diseases	2
Advances in chimeric antigen receptor-T therapies to target tumor resistance in B-cell malignancies	2
Detecting and preventing post-hematopoietic cell transplant relapse in AML	2
Editorial introduction	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
New molecules in the therapy of chronic graft-versus-host disease	2
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	2
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets	2
Direct megakaryopoiesis	2
Iron status of blood donors	2
Platelet Fc gamma RIIA: time to go beyond the unknown	2
The role of hematopoiesis in bone repair: an update	2
Editorial Introductions	2